key: cord-0854261-7dozltfa
authors: Zavala‐Jonguitud, Luis Fernando; Pérez‐García, Carla Cristina
title: Delirium triggered by COVID‐19 vaccine in an elderly patient
date: 2021-04-08
journal: Geriatr Gerontol Int
DOI: 10.1111/ggi.14163
sha: b8fe32479009f3de6d95f03bbd77222acd8c6b8a
doc_id: 854261
cord_uid: 7dozltfa

nan

Quetiapine was stopped after 1 week, and the patient has been doing well thereafter. Unfortunately, both the patient and his family rejected the second dose of the vaccine.

It is thought that many of the adverse effects of COVID-19 vaccine are triggered by the systemic inflammatory response. 4 In addition, we know that the systemic inflammatory response causes modifications in brain physiology and has been related to the sepsis-associated delirium. 5 This patient had several predisposing factors for delirium such as age, polypharmacy and sensitive impairment, and we consider that this vaccine-induced immune reaction was enough to disrupt his frail homeostasis.

To our knowledge, this is the first case report of COVID-19 vaccine associated with delirium. It is important that physicians are aware that this might happen, so they have close observation of their patients, and warn high-risk patients and their families.

The authors declare no conflict of interest. 

Acute Brain Failure

Delirium in Hospitalized Older Adults

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

A clinical perspective of sepsis-associated delirium

Delirium triggered by COVID-19 vaccine in an elderly patient. Letter to the Editor -Case Report

Letters to the Editor -Case Reports